OPO-Enriched Triglyceride Oil Through Microbial Pathway Engineering
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for producing biobased oils with specific fatty acid profiles in oleaginous microorganisms are limited, and there is a need for oils with targeted fatty acid distributions and enhanced nutritional profiles for applications such as infant formulas.
Innovation Solution
Genetic modification of microorganisms to produce oils with specific fatty acid profiles, particularly focusing on triacylglycerides (TAGs) with saturated fatty acids at the sn-2 position and specific acyl chain compositions, and the use of enzymes like lysophosphatidic acid acyltransferases (LPAATs) to enhance these profiles.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If genetic modification techniques are used to produce non-naturally occurring oils with specific fatty acid profiles, then the nutritional profile and fatty acid distribution can be improved, but the manufacturing complexity and difficulty of production increase
Solution Approach 1:
The patent modifies specific parameters of the microorganism's lipid metabolism by introducing heterologous genes (DGAT2, LPAAT) and manipulating endogenous gene expression. This changes the fatty acid composition parameters (increasing C18:1 to >50%, C16:0 to >20%, and OPO content to >40% of total TAGs) through genetic parameter adjustment rather than complex multi-step chemical synthesis processes
Solution Approach 2:
The patent uses specific enzymes (DGAT2 for diacylglycerol acyltransferase activity and LPAAT for lysophosphatidic acid acyltransferase activity) as intermediary catalysts to direct the assembly of fatty acids into specific TAG structures. These enzymatic intermediaries enable precise control over fatty acid positioning (sn-1, sn-2, sn-3) and composition without requiring complex chemical synthesis pathways
2Adaptability or versatility
If existing methods are used for producing biobased oils, then the production process is simpler, but the ability to achieve targeted fatty acid distributions and enhanced nutritional profiles is limited
Solution Approach 1:
The patent achieves versatile customization of fatty acid profiles by adjusting genetic parameters (gene overexpression levels, promoter strength, codon optimization) to produce different targeted compositions. The same genetic modification platform can be tuned to produce various fatty acid distributions (e.g., different OPO content levels, different C16:0/C18:1 ratios) without changing the fundamental production approach
Solution Approach 2:
The genetically modified microorganisms serve themselves by autonomously synthesizing the targeted fatty acid profiles through their modified metabolic pathways. The cells self-regulate the expression of DGAT2 and LPAAT genes to naturally produce the desired OPO-enriched TAG composition without requiring external intervention during the synthesis phase, simplifying the manufacturing process while achieving high adaptability
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The modified oils achieve targeted fatty acid distributions, enabling the production of nutritional supplements and infant formulas with improved nutritional profiles and specific TAG species, such as 1,3-dioleoyl-2-palmitoyl glycerol (OPO), and enhanced ergosterol content.
Implementation Method 1
the use of enzymes like lysophosphatidic acid acyltransferases (LPAATs) to enhance these profiles
Data Source
AI summary
Provided herein are triglyceride oil compositions enriched in 1,3-dioleoyl-2-palmitoylglycerol (OPO). Further provided herein are methods of producing non-naturally occurring triglyceride oil compositions enriched in OPO from non-naturally occurring microorganisms and applications thereof in a variety of end products, including, for example, polyols and nutritional supplements.